Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
20.9%
% of BMED's 147 holdings also in BBP
51.9%
% of BBP's 55 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 1.9% | 1.8% | 1.8% |
|
BIOMARIN PHARMACEUTICAL INC | 1.8% | 1.6% | 1.6% |
|
BLUEPRINT MEDICINES CORP. | 1.5% | 2.0% | 1.5% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 1.5% | 1.5% |
|
SAREPTA THERAPEUTICS INC | 1.4% | 2.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to BBP
|
BOSTON SCIENTIFIC CORP | 3.5% |
|
AMERISOURCEBERGEN CORP | 3.1% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
COOPER COS INC/THE | 2.1% |
 |
NOVO NORDISK A/S-B | 2.1% |
|
ABBVIE INC | 2.1% |
|
ALIGN TECHNOLOGY INC | 2.0% |
|
WEST PHARMACEUTICAL SERVICES | 2.0% |
 |
ARGENX SE ADR | 1.8% |
|
ELI LILLY & CO | 1.7% |
BMED Underweight Relative to BBP
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
TARSUS PHARMACEUTICALS, INC. | -3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.6% |
|
AGIOS PHARMACEUTICALS INC | -2.5% |
|
ADMA BIOLOGICS, INC. | -2.5% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.2% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |